Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-12-26
2006-12-26
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S454000, C514S459000
Reexamination Certificate
active
07153837
ABSTRACT:
This invention relates to an agent for the protection of retinal neurons which comprises, as an effective ingredient, sulfamate derivative having the following formula:and to a method for the protection of retinal neurons by using said sulfamate derivative.
REFERENCES:
patent: 4513006 (1985-04-01), Maryanoff et al.
patent: 5-5824 (1985-04-01), None
patent: WO 98/00124 (1998-01-01), None
patent: WO 00 61138 (2000-10-01), None
Abstract of Graefe's Arch. Clin. Exp. Ophthalmol., (1996), 234(7), 445-451.
Abstract of Graefe's Arch. Clin. Exp. Ophthalmol., (1996), 234(Suppl. 1), S209-S213.
Abstract of Journal of Ocular Pharmacology and Therapeutics, (1995), 11(3), 253-259.
Chang, C., et al, “Apoptotic photoreceptor cell death after traumatic retinal detachment in humans” Abstract of Archives of Ophthalmology, (1995), 113(7), 880-886.
Garcia-Venezuela, E., et al, “Programmed cell death of retinal ganglion cells during experimental glaucoma” Experimental Eye Research, (1995), 61(1), 33-44.
Johns, Donald R., et al, “Treatment of Leber's hereditary optic neuropathy: theory to practice” Seminars in Ophthalmology, (2002), 17(1), 33-38.
Markind, J.F., “Topiramate: A new antiepileptic drug” American Journal of Health-System Pharmacy, (1998), 55(6), 554-562.
Naash, M.L., et al, “Light-induced acceleration of photoreceptor degeneration in transgenic mice expressing mutant rhodopsin” Investigative Ophthalmology and Visual Science, (1996), 37(5), 775-782.
Nakamura, J., et al, “Target pharmacology of topiramate, a new antiepileptic drug” Abstract of Journal of Japanese Pharmacology, (2000), 115, 53-57.
Portera-Cailliau, C., et al, “Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa” Proc. Natl. Acad. Sci, USA, (1994), 91, 974-978.
Quigley, H.A., et al, “Retinal ganglion cell death in experimental glaucoma and after axotomy occurs in apoptosis” Investigative Ophthalmology and Visual Science, (1995), 36(5), 774-786.
Tso, M.O.M., et al., “Apoptosis leads to photoreceptor degeneration in inherited retinal dystrophy of RCS rats” Investigative Ophthalmology and Visual Science, (1994), 35(6), 2693-2699.
PCT International Search Report dated Nov. 29, 2002, for PCT Intl. Appln. No. PCT/JP02/05935.
Hara Hideaki
Ishigaki Kaoru
Kojima Hiroshi
Miyawaki Nobuaki
Okaguchi Shigehisa
Appollina Mary
McIntosh III Traviss C.
Ortho-McNeil Pharmaceutical , Inc.
LandOfFree
Agent for protection of retinal neurons does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for protection of retinal neurons, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for protection of retinal neurons will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3682476